HopeStage
Back to all studies
TerminatedNCT00270257

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

Medication studyAges 18+China + ThailandAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Hengzhou Town and 3 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMay 2008
Recruitment status
Terminated
Enrollment listed in the registry
1,251
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
China, Thailand
Age range
Over 18 Years
Official registry ID
NCT00270257
Official title
Show the full official title

A Phase III Randomized Controlled Trial to Evaluate the Efficacy of Drug Treatment in Prevention of HIV Infection and Death Among Opiate Dependent Injectors

Recruitment & locations

Terminated

Hengzhou Town, China · Nanning, China · Ürümqi, China

1 more locations
  • Chiang Mai, Thailand

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Allergy and Infectious Diseases (NIAID), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Buprenorphine/Naloxone.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies